{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:05:33Z","timestamp":1789574733948,"version":"build-2803163510"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00602","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T09:18:52Z","timestamp":1593508732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility"],"prefix":"10.3389","volume":"11","author":[{"given":"Koby","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Mama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Pinhasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00156","article-title":"Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health","volume":"8","author":"Weinstein","year":"2017","journal-title":"Front Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fpsyt.2017.00110","article-title":"An Expanding World of Novel Psychoactive Substances: Opioids","volume":"8","author":"Zawilska","year":"2017","journal-title":"Front Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5409\/wjcp.v5.i1.16","article-title":"Synthetic cannabinoids 2015: an update for pediatricians in clinical practice","volume":"5","author":"Castellanos","year":"2016","journal-title":"World J Clin Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2016.02.001","article-title":"Synthetic cannabinoids\u2014further evidence supporting the relationship between cannabinoids and psychosis","volume":"79","author":"Fattore","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/brainsci9010014","article-title":"Potential Mechanisms Underlying the Deleterious Effects of Synthetic Cannabinoids Found in Spice\/K2 Products","volume":"9","author":"Basavarajappa","year":"2019","journal-title":"Brain Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2011.08.002","article-title":"Synthetic cannabinoid use: a case series of adolescents","volume":"49","author":"Castellanos","year":"2011","journal-title":"J Adolesc Health"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04078.x","article-title":"Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings","volume":"108","author":"Hermanns-Clausen","year":"2013","journal-title":"Addiction"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3928\/00485713-20131206-08","article-title":"Synthetic Cannabinoids, Synthetic Cathinones, and Other Emerging Drugs of Abuse","volume":"43","author":"Wilson","year":"2013","journal-title":"Psychiatr Ann"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-013-3188-4","article-title":"Spicing things up: synthetic cannabinoids","volume":"228","author":"Spaderna","year":"2013","journal-title":"Psychopharmacology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/brainsci8030040","article-title":"The effects of cannabinoids on executive functions: evidence from cannabis and synthetic cannabinoids\u2014a systematic review","volume":"8","author":"Cohen","year":"2018","journal-title":"Brain Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2018.00162","article-title":"Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review from Public Health Prospective","volume":"6","author":"Cohen","year":"2018","journal-title":"Front Public Health"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2013.846288","article-title":"A survey of synthetic cannabinoid consumption by current cannabis users","volume":"35","author":"Gunderson","year":"2014","journal-title":"Subst Abuse"},{"key":"B15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to \u0394 9-THC: mechanism underlying greater toxicity","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2011.00060","article-title":"Beyond THC: the new generation of cannabinoid designer drugs","volume":"5","author":"Fattore","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114565142","article-title":"The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects","volume":"29","author":"van Amsterdam","year":"2015","journal-title":"J\u00a0Psychopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.08.039","article-title":"Intoxication from smoking \u201cspice","volume":"57","author":"Simmons","year":"2011","journal-title":"Ann Emergency Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/can.2018.0047","article-title":"Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders","volume":"4","author":"Theunissen","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14407","article-title":"Modulatory effects of cannabinoids on brain neurotransmission","volume":"50","author":"Cohen","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03602532.2018.1428343","article-title":"Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems","volume":"50","author":"Fantegrossi","year":"2018","journal-title":"Drug Metab Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: a pharmacological fMRI study with\u0394 9-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112446530","article-title":"Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images","volume":"26","author":"Ballard","year":"2012","journal-title":"J Psychopharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990436","article-title":"Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies","volume":"20","author":"Bossong","year":"2014","journal-title":"Curr Pharmaceut Design"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.06.019","article-title":"Altered affective response in marijuana smokers: an FMRI study","volume":"105","author":"Gruber","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-1600.2011.00427.x","article-title":"Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers","volume":"18","author":"Bedi","year":"2013","journal-title":"Addict Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2004.07.032","article-title":"Abnormal brain activity in prefrontal brain regions in abstinent marijuana users","volume":"23","author":"Eldreth","year":"2004","journal-title":"Neuroimage"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0298-7","article-title":"Long-term effects of frequent cannabis use on working memory and attention: an fMRI study","volume":"185","author":"Jager","year":"2006","journal-title":"Psychopharmacology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160822151323","article-title":"Brain imaging studies on the cognitive, pharmacological and neurobiological effects of cannabis in humans: evidence from studies of adult users","volume":"22","author":"Weinstein","year":"2016","journal-title":"Curr Pharmaceut Design"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031731","article-title":"Short-and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats","volume":"7","author":"Abush","year":"2012","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2005.12.002","article-title":"Cannabinoids and prefrontal cortical function: insights from preclinical studies","volume":"30","author":"Egerton","year":"2006","journal-title":"Neurosci Biobehav Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02739-6","article-title":"Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2","volume":"877","author":"Lawston","year":"2000","journal-title":"Brain Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.02.099","article-title":"Cannabinoid modulation of executive functions","volume":"585","author":"Pattij","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1636-07.2007","article-title":"Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex","volume":"27","author":"Bambico","year":"2007","journal-title":"J Neurosci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.11.020","article-title":"Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission","volume":"37","author":"Bambico","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01755-7","article-title":"Involvement of 5-hydroxytryptamine neuronal system in \u03949-tetrahydrocannabinol-induced impairment of spatial memory","volume":"445","author":"Egashira","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104047277","article-title":"Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats","volume":"18","author":"O\u2019Shea","year":"2004","journal-title":"J Psychopharmacol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1369-1600.2010.00227.x","article-title":"Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status","volume":"16","author":"Winsauer","year":"2011","journal-title":"Addict Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.112361","article-title":"Link between personality and response to THC exposure","volume":"379","author":"Kardash","year":"2020","journal-title":"Behav Brain Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.psychres.2018.01.046","article-title":"Evaluation of cognitive functions in individuals with synthetic cannabinoid use disorder and comparison to individuals with cannabis use disorder","volume":"262","author":"Cengel","year":"2018","journal-title":"Psychiatry Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5350\/DAJPN2014270407","article-title":"Clinical characteristics and laboratory test results of patients admitted to outpatient clinic for synthetic cannabinoid usage","volume":"27","author":"Bozkurt","year":"2014","journal-title":"Dusunen Adam"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2015.10.013","article-title":"The behavioral profile of spice and synthetic cannabinoids in humans","volume":"126","author":"M\u00fcller","year":"2016","journal-title":"Brain Res Bull"},{"key":"B47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/01.pra.0000413274.09305.9c","article-title":"Synthetic cannabinoid use: recognition and management","volume":"18","author":"Castellanos","year":"2012","journal-title":"J Psychiatr Practice\u00ae"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.637610","article-title":"Spice: a new \u201clegal\u201d herbal mixture abused by young active duty military personnel","volume":"33","author":"Bebarta","year":"2012","journal-title":"Subst Abuse"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15m09938","article-title":"Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study","volume":"77","author":"Shalit","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2014.00054","article-title":"Gone to pot\u2013a review of the association between cannabis and psychosis","volume":"5","author":"Radhakrishnan","year":"2015","journal-title":"Front Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.2174\/157340007781369658","article-title":"Cannabis use, first-episode psychosis, and schizotypy: a summary and synthesis of recent literature","volume":"3","author":"Compton","year":"2007","journal-title":"Curr Psychiatry Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-009-0024-2","article-title":"Cannabis and psychosis\/schizophrenia: human studies","volume":"259","author":"D\u2019Souza","year":"2009","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"B54","first-page":"30","article-title":"Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia","volume":"32","author":"Solowij","year":"2007","journal-title":"J Psychiatry Neurosci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2003.12.001","article-title":"The relationship between cannabis use and schizotypal symptoms","volume":"19","author":"Bailey","year":"2004","journal-title":"Eur Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0165-1781(01)00358-4","article-title":"Cannabis use correlates with schizotypal personality traits in healthy students","volume":"109","author":"Dumas","year":"2002","journal-title":"Psychiatry Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.00355","article-title":"Personality Traits and Psychotic Proneness among Chronic Synthetic Cannabinoid Users","volume":"11","author":"Cohen","year":"2020","journal-title":"Front Psychiatry"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291707002619","article-title":"Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample","volume":"38","author":"Barkus","year":"2008","journal-title":"psychol Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1017\/S0033291702006384","article-title":"Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study","volume":"33","author":"Verdoux","year":"2003","journal-title":"Psychol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4546-4","article-title":"The effects of synthetic cannabinoids on executive function","volume":"234","author":"Cohen","year":"2017","journal-title":"Psychopharmacology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2018.07.095","article-title":"The effects of synthetic cannabinoids (SCs) on brain structure and function","volume":"28","author":"Livny","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.4.555","article-title":"The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria","volume":"17","author":"Raine","year":"1991","journal-title":"Schizophr Bull"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2011.05.021","article-title":"Measurement invariance of the Schizotypal Personality Questionnaire-Brief across gender and age","volume":"190","author":"Fonseca-Pedrero","year":"2011","journal-title":"Psychiatry Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","article-title":"Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation","volume":"8","author":"Beck","year":"1988","journal-title":"Clin Psychol Rev"},{"key":"B65","volume-title":"Manual for the state-trait anxiety inventory. Manual for the state-trait anxiety inventory","author":"Spielberger","year":"1983"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-psych-113011-143750","article-title":"Executive functions","volume":"64","author":"Diamond","year":"2013","journal-title":"Annu Rev Psychol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1006\/nimg.2000.0685","article-title":"Mapping motor inhibition: conjunctive brain activations across different versions of go\/no-go and stop tasks","volume":"13","author":"Rubia","year":"2001","journal-title":"Neuroimage"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110382465","article-title":"Does intravenous \u03949-tetrahydrocannabinol increase dopamine release? A SPET study","volume":"25","author":"Barkus","year":"2011","journal-title":"J Psychopharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropsychologia.2007.07.015","article-title":"Meta-analysis of Go\/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent","volume":"46","author":"Simmonds","year":"2008","journal-title":"Neuropsychologia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hbm.20131","article-title":"N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies","volume":"25","author":"Owen","year":"2005","journal-title":"Hum Brain Mapp"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acp063","article-title":"Is the n-back task a valid neuropsychological measure for assessing working memory","volume":"24","author":"Miller","year":"2009","journal-title":"Arch Clin Neuropsychol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1080\/09658211003702171","article-title":"The concurrent validity of the N-back task as a working memory measure","volume":"18","author":"Jaeggi","year":"2010","journal-title":"Memory"},{"key":"B73","article-title":"Some effects of frontal lobectomy in man","volume-title":"Frontal Granular Cortex Behav","author":"Milner","year":"1964"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.10.909","article-title":"Neuropsychological performance in long-term cannabis users","volume":"58","author":"Pope","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291709992078","article-title":"Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia","volume":"40","author":"Scholes","year":"2010","journal-title":"psychol Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114527359","article-title":"Emotional processing deficits in chronic cannabis use: a replication and extension","volume":"28","author":"Hindocha","year":"2014","journal-title":"J Psychopharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugalcdep.2010.05.004","article-title":"Processing dynamic facial affect in frequent cannabis-users: evidence of deficits in the speed of identifying emotional expressions","volume":"112","author":"Platt","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S107622","article-title":"Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients","volume":"12","author":"Altintas","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703413","article-title":"D2 dopamine receptors enable \u03949-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration","volume":"130","author":"Nava","year":"2000","journal-title":"Br J Pharmacol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2013.01.018","article-title":"\u0394 9 Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques","volume":"235","author":"Wright","year":"2013","journal-title":"Neuroscience"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03055-X","article-title":"\u0394 9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study","volume":"948","author":"Pistis","year":"2002","journal-title":"Brain Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1523\/JNEUROSCI.4872-05.2006","article-title":"The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum","volume":"26","author":"Kawamura","year":"2006","journal-title":"J Neurosci"},{"key":"B83","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/mp.2014.14","article-title":"CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex","volume":"19","author":"Cass","year":"2014","journal-title":"Mol Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015058","article-title":"Impaired attribution of emotion to facial expressions in anxiety and major depression","volume":"5","author":"Demenescu","year":"2010","journal-title":"PloS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3389\/fnbeh.2011.00057","article-title":"Effects of endocannabinoid system modulation on cognitive and emotional behavior","volume":"5","author":"Zanettini","year":"2011","journal-title":"Front Behav Neurosci"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00602\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T09:18:57Z","timestamp":1593508737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00602\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":85,"alternative-id":["10.3389\/fpsyt.2020.00602"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00602","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"article-number":"602"}}